YouNick Mint
VC Fund
Poznan, Poland
YouNick Mint is an investment team managed by business practitioners working together for years in the areas of Healthcare (pharma, medical devices, innovative materials and medical devices) and Industry 4.0 (materials technology, ICT, RPA, PropTech). Younick has invested in nearly 50 innovative early-stage companies, he has invested in nearly 50companies through four investment vehicles, with several exits, including the sale of 100% of a portfolio company SmartPharma to a global pharmaceutical company. Under its current fund - Open Innovation by YouNick Mint, it invests jointly with private co-investors amounts of €1 to €2 million at 60%/40% parity. Partners of the YouNick team include private investors, business angels, as well as the National Research and Development Center and PFR Ventures.
- Total investments:
- 25
- Last investment:
- Lead investor:
- 64%
Last updated:
For AI agents: llms.txt
Industries YouNick Mint invests in
Stages YouNick Mint invests in
Countries YouNick Mint invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $259k–$3.2M
- Pre-Seed
- $242k–$533k
Investment Focus
Industry
- Health Care 6 (24%)
- Software 5 (20%)
- Manufacturing 4 (16%)
- Artificial Intelligence 4 (16%)
- Biotechnology 3 (12%)
Stage
- Pre-Seed 14 (56%)
- Seed 6 (24%)
- Venture - Series Unknown 2 (8%)
- Series A 1 (4%)
- Funding Round 1 (4%)
Country
- Poland 20 (80%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aleksander Kłósek
Managing Partner
|
Managing Partner | Total investments: 3 | Find email | |
|
Michał Janer
Researcher / Business Office Manager; Researcher / Business Office Manager
|
Researcher / Business Office Manager; Researcher / Business Office Manager | Total investments: 0 | Find email | |
Piotr Danielewicz
Investment Manager
|
Investment Manager | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Intelliseq
|
Intelliseq is a genome informatics company established in 2014 by a group of scientists fascinated with pharmacogenomics and transcriptomics. Its aim is to support whole genome scientific research and genetic diagnosis process. The company consists of an interdisciplinary team of experts in the field of genomics, molecular biology, bioinformatics,and software development. Intelliseq is focused on the development of novel algorithms and bioinformatic tools devoted to interpretation of human DNA sequence. Team created a platform analyzing human genome for precision medicine. Now, Intelliseq is quickly growing to fill a void in a translation of genetics knowledge also into the products market. In 2017, the company introduced to the US market its first mobile application for genetics, MyTraits Sport. The future of Intelliseq solutions is heading in the direction of AI based mobile applications able to predict personalized risk and support treatment decisions. | $4.9M / Mar 28, 2025 | |
SUPERSONIC Food
|
SUPERSONIC is a brand of products that replace traditional meals and beverages (meal replacement product), are innovative in their recipe and consist of the best plant components.SUPERSONIC are products of plant origin created by scientists, nutritionists and biotechnologists, that provide full nutritional value, build immunity and delay theaging process. | $1.6M / Seed / Mar 15, 2023 | |
Prosoma
|
Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $3.6M / Series A / Dec 19, 2022 | |
|
Prosoma
|
Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $3.2M / Seed / Dec 19, 2022 | |
|
Intelliseq
|
Intelliseq is a genome informatics company established in 2014 by a group of scientists fascinated with pharmacogenomics and transcriptomics. Its aim is to support whole genome scientific research and genetic diagnosis process. The company consists of an interdisciplinary team of experts in the field of genomics, molecular biology, bioinformatics,and software development. Intelliseq is focused on the development of novel algorithms and bioinformatic tools devoted to interpretation of human DNA sequence. Team created a platform analyzing human genome for precision medicine. Now, Intelliseq is quickly growing to fill a void in a translation of genetics knowledge also into the products market. In 2017, the company introduced to the US market its first mobile application for genetics, MyTraits Sport. The future of Intelliseq solutions is heading in the direction of AI based mobile applications able to predict personalized risk and support treatment decisions. | $1.6M / Venture - Series Unknown / Nov 07, 2022 | |
BlueKey
|
Connected Realities. Our mission is to enable escape room creators to share their passion with the whole world | $1.4M / Pre-Seed / Dec 30, 2021 | |
Cluee.app
|
Cluee.app helps freelance businesses organize their life as a freelancer in a beautiful way. | $260.5K / Pre-Seed / Mar 10, 2021 | |
nCage Therapeutics
|
nCase Therapeutics is a developer of advanced artificial technologies aimed at triggering the formation of protein cages. The company's protein cages are specialized synthetic Virus-Like Particles (VLPs), designed to either display biological materials on their surface or facilitate the transport of molecules, such as nucleic acids orproteins, into the interior of cells. This technology enables a high-density, multivalent display of antigens, closely resembling the properties and functionality of viruses. | Seed / Jan 01, 2021 | |
MAB Robotics
|
MAB Robotics is a developer of walking robots aimed at making advanced robotics more accessible. The company primarily focuses on legged robotics and high-performance brushless actuators. It offers customized robotic solutions for inspection and maintenance services, enabling clients to meet their specific requirements. | $268.5K / Pre-Seed / Sep 02, 2020 | |
|
coat-it
|
$533.4K / Pre-Seed / Aug 10, 2020 | ||
| See all 25 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does YouNick Mint invest in?
YouNick Mint invests primarily in Health Care, Software and Manufacturing startups, most often at Pre-Seed and Seed stage. Most of the 25 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is YouNick Mint's check size?
YouNick Mint typically joins rounds of $259k–$3.2M at Seed and $242k–$533k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds YouNick Mint participates in.
How do I contact YouNick Mint?
Public channels for YouNick Mint include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at YouNick Mint?
The team at YouNick Mint includes Aleksander Kłósek (Managing Partner), Michał Janer (Researcher / Business Office Manager; Researcher / Business Office Manager) and Piotr Danielewicz (Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
